Patients at risk for developing heart failure with preserved ejection fraction (HFpEF) will undergo a structured clinical assessment, transthoracic echocardiography and pulse-wave analysis to investigate the association of arterial stiffening and the development of cardiac diastolic dysfuntion and HFpEF.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in HFA-PEFF-Score
Timeframe: 24 months
Development of HFpEF
Timeframe: 24 months
Composite endpoint cardiovascular events
Timeframe: 24 months